These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11797067)

  • 21. Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats.
    Kitamura Y; Araki H; Suemaru K; Gomita Y
    Pharmacol Biochem Behav; 2002 May; 72(1-2):397-402. PubMed ID: 11900811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
    Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome.
    Hayslett RL; Tizabi Y
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):409-15. PubMed ID: 14643839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats.
    O'Dell LE; Torres OV; Natividad LA; Tejeda HA
    Neurotoxicol Teratol; 2007; 29(1):17-22. PubMed ID: 17184972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration.
    Slotkin TA; Seidler FJ
    Neurotoxicol Teratol; 2007; 29(1):10-6. PubMed ID: 16919421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.
    Grottick AJ; Corrigall WA; Higgins GA
    Psychopharmacology (Berl); 2001 Sep; 157(3):292-8. PubMed ID: 11605085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
    Willins DL; Meltzer HY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of acetylcholine receptors and 5-HT2 receptors have additive effects in the suppression of neocortical high-voltage spindles in aged rats.
    Jäkälä P; Puolivali J; Björklund M; Koivisto E; Riekkinen P
    Psychopharmacology (Berl); 1997 Aug; 132(3):270-80. PubMed ID: 9292627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neuropharmacology; 2010 Feb; 58(2):429-35. PubMed ID: 19772864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.
    Darmani NA; Martin BR; Glennon RA
    Eur J Pharmacol; 1990 Sep; 186(1):115-8. PubMed ID: 2282932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats.
    Matuszewich L; Yamamoto BK
    Psychopharmacology (Berl); 2003 Sep; 169(2):169-75. PubMed ID: 12768269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation.
    Chaouloff F; Baudrie V; Coupry I
    Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
    Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE
    Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
    Welch JE; Saphier D
    J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotine withdrawal suppresses nicotinic modulation of long-term potentiation induction in the hippocampal CA1 region.
    Yamazaki Y; Fujii S; Jia Y; Sumikawa K
    Eur J Neurosci; 2006 Nov; 24(10):2903-16. PubMed ID: 17156213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM; Chang YH
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):223-32. PubMed ID: 11699570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.